Concepedia

Shu‐Ying Chang

SC

14

Publications

644

Citations

14

H-Index

1997

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Chang Gung University

Chang Gung Memorial Hospital

Edward Hines, Jr. VA Hospital

Illinois Institute of Technology

Shu‐Ying Chang is an author at Bristol-Myers Squibb (United States) specializing in medicine, engineering, and pharmacokinetics.

Top concepts

Publications per year

1997–2020

14

Publications

14

Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19

Tatyana Zvyaga, Shu‐Ying Chang, Cliff Chen et al. · Drug Metabolism and Disposition · 2012 · 120 citations

The role of adipose protein derived hydrogels in adipogenesis

Shiri Uriel, Jung‐Ju Huang, Monica L. Moya et al. · Biomaterials · 2008 · 100 citations

, , +9

Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections

Aberra Fura, Ashish K. Khanna, Viral Vyas et al. · Drug Metabolism and Disposition · 2009 · 98 citations

Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro

Shu‐Ying Chang, Wenying Li, Sarah C. Traeger et al. · Drug Metabolism and Disposition · 2008 · 59 citations

High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine

Shu‐Ying Chang, Daisy B. Whigan, Nimish N. Vachharajani et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1997 · 48 citations

, , +13

Rows per page

1–5 of 14